메뉴 건너뛰기
The Lancet Neurology
Volumn 13, Issue 3, 2014, Pages 234-235
New evidence for teriflunomide in multiple sclerosis
Author keywords

[No Author keywords available]
Indexed keywords

CROTONATES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TOLUIDINES;
EID: 84894253670     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70012-2     Document Type: Note
Times cited : (4)
References (8)
  • 1
    • 84885635833 scopus 로고    scopus 로고
    • Multiple sclerosis: prospects and promise
    • Hauser SL, Chan JR, Oksenberg JR Multiple sclerosis: prospects and promise. Ann Neurol 2013, 74:317-327.
    • (2013) Ann Neurol , vol.74 , pp. 317-327
    • Hauser, S.L.1    Chan, J.R.2    Oksenberg, J.R.3
  • 3
    • 80053533877 scopus 로고    scopus 로고
    • Randomized trial of oral teriflunomide for relpasing multiple sclerosis
    • O'Connor P, Wolinsky JS, Confavreux C, et al. Randomized trial of oral teriflunomide for relpasing multiple sclerosis. N Engl J Med 2011, 365:1293-1303.
    • (2011) N Engl J Med , vol.365 , pp. 1293-1303
    • O'Connor, P.1    Wolinsky, J.S.2    Confavreux, C.3
  • 4
    • 84894271594 scopus 로고    scopus 로고
    • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
    • for the the TOWER Trial Group, published online Jan 23.
    • Confavreux C, O'Connor P, Comi G, et al. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 2014, for the the TOWER Trial Group, published online Jan 23. http://dx.doi.org/10.1016/S1474-4422(13)70308-9.
    • (2014) Lancet Neurol
    • Confavreux, C.1    O'Connor, P.2    Comi, G.3
  • 5
    • 84866423965 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
    • Gold R, Kappos L, Arnold DL, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012, 367:1098-1107.
    • (2012) N Engl J Med , vol.367 , pp. 1098-1107
    • Gold, R.1    Kappos, L.2    Arnold, D.L.3
  • 6
    • 79955803328 scopus 로고    scopus 로고
    • A critical appraisal of treatment decisions in multiple sclerosis-old versus new
    • Kieseier BC, Stüve O A critical appraisal of treatment decisions in multiple sclerosis-old versus new. Nat Rev Neurol 2011, 7:255-262.
    • (2011) Nat Rev Neurol , vol.7 , pp. 255-262
    • Kieseier, B.C.1    Stüve, O.2
  • 7
    • 77955799815 scopus 로고    scopus 로고
    • Oral fingolimod (FTY720) for relapsing multiple sclerosis
    • Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006, 355:1124-1140.
    • (2006) N Engl J Med , vol.355 , pp. 1124-1140
    • Kappos, L.1    Antel, J.2    Comi, G.3
  • 8
    • 76149140914 scopus 로고    scopus 로고
    • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
    • Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010, 362:402-415.
    • (2010) N Engl J Med , vol.362 , pp. 402-415
    • Cohen, J.A.1    Barkhof, F.2    Comi, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.